Ophthalmology Innovation Summit @ RETINA, Vancouver (BC), Canada

GenSight Biologics reports €49 million cash position as of March 31, 2018 and provides update on GS010

GenSight Biologics Reports Full Year 2017 Financial Results

GenSight Biologics reports €55 million 2017 year-end cash position and provides corporate update

GenSight Biologics Appoints Julio Benedicto as Vice President of Marketing

GenSight Biologics to Participate in Multiple Conferences in November

GenSight Biologics Reports its Cash Position as of September 30, 2017

GenSight Biologics Appoints Barrett Katz as Chief Medical Officer

GenSight Biologics to Attend Chardan Gene Therapy Conference

GenSight Biologics Reports Interim Financial Results for the First Half of 2017